Pain Management Based on NCCN Guideline in Patients with Lung Cancer.
10.4046/trd.2009.67.3.221
- Author:
Hyeon Tae KIM
1
;
Kyung Won KOH
;
Yeo Myeong KIM
;
Min Soo KANG
;
Hee Sun NOH
;
Hye Ryoun KIM
;
Cheol Hyeon KIM
;
Jae Cheol LEE
Author Information
1. Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological & Medical Sciences, Seoul, Korea. jclee@kcch.re.kr
- Publication Type:Original Article
- Keywords:
Pain;
NCCN guideline;
Lung neoplasms
- MeSH:
Humans;
Lung;
Lung Neoplasms;
Pain Management
- From:Tuberculosis and Respiratory Diseases
2009;67(3):221-225
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Pain is one of the most troublesome problems caused by malignancy. We evaluated the change in pain status according to observance of NCCN guidelines in lung cancer patients. METHODS: Lung cancer patients complaining of pain at admission were examined. The pain was assessed with visual analogue scale (VAS) for 20 days and moderate-to-severe pain was defined as more than VAS level 3. The guideline observance was classified as high (more than 80%), medium (50~79%) and low (less than 50%). RESULTS: Among the total 91 lung cancer patients with pain, 34 patients (37%) had moderate-to-severe pain. Their average VAS score at admission was 5.6. It decreased to 2.9 after a 20-day period of pain management. The time to reach a VAS less than 3 was 3 days in a high guideline observance group, while it took 6 days in a low observance group. In addition, the pain in the high observance group was controlled to less than 3 VAS level in 86% of patients, whereas only 25% of patients in the low observance group succeeded. CONCLUSION: Pain was more effectively controlled when the dose of drugs was modified according to NCCN guidelines in lung cancer patients indicating the importance of guideline observance in pain management.
